Fatigue in prostate cancer survivors treated with definitive radiotherapy and LHRH analogs.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1480, doi. 10.1002/pros.21183
- By:
- Publication type:
- Article
Works matching IS 02704137 AND DT 2010 AND VI 70 AND IP 13
Results: 12
1
2
Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1388, doi. 10.1002/pros.21172
- By:
- Publication type:
- Article
3
High-resolution animal PET imaging of prostate cancer xenografts with three different <sup>64</sup>Cu-labeled antibodies against native cell-adherent PSMA.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1413, doi. 10.1002/pros.21176
- By:
- Publication type:
- Article
4
A novel in vitro assay of tumor-initiating cells in xenograft prostate tumors.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1379, doi. 10.1002/pros.21171
- By:
- Publication type:
- Article
5
Organ-wide telomeric status in diseased and disease-free prostatic tissues.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1471, doi. 10.1002/pros.21182
- By:
- Publication type:
- Article
6
A transcriptional signature associated with the onset of benign prostate hyperplasia in a canine model.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1402, doi. 10.1002/pros.21175
- By:
- Publication type:
- Article
7
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1437, doi. 10.1002/pros.21179
- By:
- Publication type:
- Article
8
Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1461, doi. 10.1002/pros.21181
- By:
- Publication type:
- Article
9
Serum prostate-specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1395, doi. 10.1002/pros.21174
- By:
- Publication type:
- Article
10
Vitamin D pathway gene variants and prostate cancer prognosis.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1448, doi. 10.1002/pros.21180
- By:
- Publication type:
- Article
11
Immunohistochemical examination of the mTORC1 pathway in high grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinomas (PCa): A tissue microarray study (TMA).
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1429, doi. 10.1002/pros.21178
- By:
- Publication type:
- Article
12
Loss of the matriptase inhibitor HAI-2 during prostate cancer progression.
- Published in:
- Prostate, 2010, v. 70, n. 13, p. 1422, doi. 10.1002/pros.21177
- By:
- Publication type:
- Article